The nasal photodisinfection study met the primary endpoint. Staphylococcus aureus (S. aureus) was eliminated or significantly decreased in 86% of carriers (p<0.001) in the trial. The study also met the secondary endpoint. Analysis of… Read More
VANCOUVER, BC — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that the United… Read More
RICHMOND, BC — A new government initiative will create jobs and economic opportunities for British Columbians by supporting made-in-B.C. companies to develop and sell clean-tech solutions locally, so they can… Read More
The Canada Research Coordinating Committee (CRCC) has released its 2021-22 progress report, Moving Forward. The report illustrates how Canada’s federal research funding organizations worked together to help sustain Canada’s research enterprise through the… Read More
The conditions for the positive recommendation is supported by the findings of the Phase 3 SOLSTICE Study.1,2 TORONTO, ON — Takeda Canada Inc. (“Takeda”) is pleased to announce that the Canada’s Drug… Read More
